The comparison of nasal irrigation outcome between 3% NaCl and 0.9% NaCl in adults majority with intermittent allergic rhinitis: A randomized double-blind study

被引:2
|
作者
Yata, Kedsaraporn [1 ]
Srivanitchapoom, Chonticha [1 ]
机构
[1] Phayao Hosp, Otolaryngol Unit, 269 Moo 11, Muang Phayao, Phayao, Thailand
关键词
nasal irrigation; 3% NaCl; 0.9% NaCl; hypertonic saline; allergic rhinitis; HYPERTONIC SALINE; MUCOCILIARY CLEARANCE; CHILDREN; ASTHMA; CONGESTION; IMPACT;
D O I
10.12932/AP-140520-0844
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Management of allergic rhinitis with oral antihistamine and steroid nasal spray are the standard treatment which is recommended by Allergic Rhinitis and its Impact on Asthma guidelines. In addition, nasal irrigation as an adjuvant therapy also provides a satisfactory result. Objective: To compare the treatment outcome in adults majority with intermittent allergic rhinitis who receive different concentrations of nasal irrigation. Methods: The prospective randomized double-blind study was performed in 80 patients. All patients were prescribed oral antihistamine and nasal irrigated solution between 3% NaCl and 0.9% NaCl. Nasal congestion and rhinorrhea were evaluated at baseline, first and second weeks after treatment. Assessments were measured by nasal congestion visual analog scale rhinorrhea visual analog scale, inferior turbinate size, and peak nasal expiratory flow rate (PNEFR). A p value of < 0.05 was considered statistically significant. Results: There were 40 patients in each group of the study. Patients reported satisfactory experience after using saline irrigation at first and second weeks in both solutions (p value < 0.001). However, when compared between groups, no significant differences for all parameters were reported. PNEFR showed good results after the first week of 3% NaCl irrigation (p value = 0.001), while 0.9% NaCl had good results after the second week (p value < 0.001). Conclusion: Both add-on treatments have a significant improvement of all 4 parameters assessed in the study: nasal congestion, rhinorrhca, inferior turbinate size and PNEFR. Of note, 3% NaCl but not 0.9 NaCl had improved the PNEFR earlier from 1 week of the treatment.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [41] DOUBLE-BLIND COMPARISON BETWEEN TERFENADINE (120MG/DAY) AND LORATADINE (10MG/DAY) IN PATIENTS WITH SEASONAL ALLERGIC RHINITIS
    FUCHS, T
    ULRICH, R
    BUTT, U
    ALLERGOLOGIE, 1992, 15 (10) : 336 - 340
  • [42] Effects and safety of intranasal phototherapy for allergic rhinitis Study protocol for a single-center, randomized, double-blind, parallel, placebo-controlled, investigator-initiated, pilot study
    Kang, Jeongin
    Lee, Goeun
    Kim, Jeonghun
    Kim, Youngeun
    Park, Sunju
    Lee, Donghyo
    MEDICINE, 2020, 99 (30) : E20835
  • [43] Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: A randomized, double-blind clinical trial
    Mahatme, Mohini Sachin
    Dakhale, Ganesh Natthuji
    Tadke, Kanchan
    Hiware, Sachin Keshaorao
    Dudhgaonkar, S. D.
    Wankhede, Sumit
    INDIAN JOURNAL OF PHARMACOLOGY, 2016, 48 (06) : 649 - 653
  • [44] A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study)
    Pedro Ojeda
    Núria Piqué
    Alicia Alonso
    Julio Delgado
    Francisco Feo
    Juan Manuel Igea
    Ana Navarro
    José María Olaguibel
    Javier Subiza
    Carles Nieto
    Morgan Andersson
    Allergy, Asthma & Clinical Immunology, 9
  • [45] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
    Lee, Su Won
    Choi, Jin Kwan
    Lyu, Yee Ran
    Yang, Won Kyung
    Kim, Seung Hyung
    Kim, Je Hyun
    Kim, Si Yeon
    Kang, Weechang
    Jung, In Chul
    Lee, Beom Joon
    Choi, Jun Yong
    Kim, Taesoo
    Park, Yang Chun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [46] Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes
    Steveling, Esther Helen
    Lao-Araya, Mongkol
    Koulias, Christopher
    Scadding, Guy
    Eifan, Aarif
    James, Louisa K.
    Dumitru, Alina
    Penagos, Martin
    Calderon, Moises
    Andersen, Peter Sejer
    Shamji, Mohamed
    Durham, Stephen R.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2015, 5
  • [47] A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
    Anne K Ellis
    Yifei Zhu
    Lisa M Steacy
    Terry Walker
    James H Day
    Allergy, Asthma & Clinical Immunology, 9
  • [48] A four-way, double-blind, randomized, placebo controlled study to determine the efficacy and speed of azelastine nasal spray, versus loratadine, and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
    Ellis, Anne K.
    Zhu, Yifei
    Steacy, Lisa M.
    Walker, Terry
    Day, James H.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2013, 9
  • [49] Limosilactobacillus reuteri DSM-17938 for preventing cough in adults with mild allergic asthma: A double-blind randomized placebo-controlled cross-over study
    Satia, Imran
    Cusack, Ruth
    Stevens, Catie
    Schlatman, Abbey
    Wattie, Jennifer
    Mian, Firoz
    Killian, Kieran J.
    O'Byrne, Paul M.
    Bienenstock, John
    Forsythe, Paul
    Gauvreau, Gail M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (09) : 1133 - 1143
  • [50] Efficacy and Tolerability Comparison of Ebastine 10 and 20mg with Loratadine 10mgA Double-Blind, Randomised Study in Patients with Perennial Allergic Rhinitis
    Robert J. Davies
    Clinical Drug Investigation, 1998, 16 : 413 - 420